Product image of Nasonex (Mometasone Furoate) supplied by GNH India

Nasonex

Active Ingredient:
Mometasone Furoate
Origin:
EU

Nasonex (Mometasone Furoate)

Mometasone furoate, the active ingredient in Nasonex, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis, seasonal and perennial allergic rhinitis, and nasal polyps in adults and children as prescribed, reducing nasal inflammation, congestion, itching, sneezing and improving overall nasal airflow and patient quality of life.

GNH India supplies Nasonex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality assurance, regulatory compliance, and reliable logistics for global distribution.

Manufacturer / TM Owner

N.V. Organon

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Nasonex, a topical corticosteroid, is indicated for inflammatory conditions of the nasal passages.
  • Allergic rhinitis: reduces nasal congestion, itching, sneezing and rhinorrhea.
  • Seasonal allergic rhinitis: provides symptom relief during pollen seasons.
  • Perennial allergic rhinitis: controls year‑round nasal inflammation.
  • Nasal polyps: helps shrink polyps and improve nasal airflow.

How It Works

  • Mometasone furoate binds to intracellular glucocorticoid receptors in nasal mucosal cells, altering gene transcription and suppressing the release of pro‑inflammatory cytokines, chemokines and mediators such as histamine and leukotrienes. This anti‑inflammatory action decreases vascular permeability and edema, leading to reduced nasal swelling and symptom relief. The localized effect minimizes systemic exposure while providing sustained anti‑inflammatory activity throughout the dosing interval.

Side Effects

Nasonex may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects

  • Nasal irritation or burning: mild discomfort at the site of application.
  • Headache: transient headache following use.
  • Epistaxis: occasional nosebleeds.
  • Throat irritation: mild soreness or dryness.

Serious or Rare Side Effects

  • Nasal septal perforation: rare tissue damage requiring medical attention.
  • Vision changes: rare blurred vision or cataract formation.
  • Adrenal suppression: systemic corticosteroid effect with prolonged high‑dose therapy.

Precautions & Warnings

Before prescribing Nasonex, clinicians should consider several safety and handling precautions.

  • Assess infection: avoid use in patients with active nasal or sinus infections.
  • Monitor growth: pediatric patients should have growth monitored during long‑term therapy.
  • Evaluate glaucoma: caution in patients with glaucoma or cataracts.
  • Use with caution: avoid concomitant use of other intranasal corticosteroids.
  • Store at room temperature: keep the spray bottle in its original packaging, protect from moisture and heat.

Avoid Interactions

Nasonex can interact with other medicines, primarily through additive corticosteroid effects.

Major Interactions (Avoid)

  • Systemic corticosteroids: increased risk of systemic steroid side effects.
  • Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise local drug exposure.

Moderate Interactions (Monitor Closely)

  • Antifungal azoles: monitor for enhanced nasal effects.
  • Antiretrovirals (e.g., ritonavir): may increase local concentration.
  • Nasal decongestants: potential for increased nasal irritation.

Frequently Asked Questions

Nasonex is prescribed for allergic rhinitis, including both seasonal and perennial forms, as well as for the management of nasal polyps. By reducing inflammation within the nasal passages, it helps alleviate symptoms such as congestion, itching, sneezing, and nasal discharge.

Mometasone furoate binds to glucocorticoid receptors in the cells lining the nose. This binding modifies gene expression, leading to decreased production of inflammatory cytokines, chemokines, and mediators. The result is reduced swelling, mucus production, and overall nasal inflammation.

The appropriate dose of Nasonex is set by a qualified prescriber based on the patient’s age, severity of symptoms, and specific indication. Physicians may adjust the number of sprays per nostril according to clinical response and safety considerations.

Safety data for mometasone furoate in pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits against any possible risks before prescribing Nasonex to pregnant or nursing women.

To request Nasonex, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Nasonex contains mometasone furoate, a high‑potency corticosteroid with strong local anti‑inflammatory activity and minimal systemic absorption. Compared with older agents such as beclomethasone, it often provides effective symptom control at lower spray volumes, though individual response may vary.

Store Nasonex at room temperature, preferably below 25 °C. Keep the spray bottle in its original packaging, protect it from moisture, direct sunlight and excessive heat to maintain product stability.

Nasonex is delivered as a metered‑dose nasal spray. The patient should gently blow the nose, insert the tip into each nostril, close the opposite nostril, and press the pump while breathing in gently. The recommended number of sprays per nostril is determined by the prescriber.

Serious adverse events, although rare, include nasal septal perforation, adrenal suppression with prolonged high‑dose use, and vision changes such as cataracts or blurred vision. Patients should report persistent nosebleeds, unusual eye symptoms, or signs of systemic steroid effects to their clinician promptly.

Nasonex is contraindicated in individuals with known hypersensitivity to mometasone furoate or any component of the formulation. It should also be avoided in patients with active untreated nasal or sinus infections, and caution is advised for those using other intranasal corticosteroids simultaneously.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mometasone Furoate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT